Sign in

Glioblastoma

Current status: Treatable, not yet curable

A fast-growing cancer that starts in the brain and can cause headaches, seizures, and changes in thinking or mood. It is the most common brain cancer in adults, and men get it more often than women. Treatment is usually surgery to remove as much of it as possible, then radiotherapy with a daily chemotherapy medicine called temozolomide. Researchers are testing new treatments in people, including medicines that help the immune system fight the cancer.

Read more about glioblastoma
Where research stands todayUpdated 15 Nov 2026

Trial-stage treatments and research studies you can join

Filters

Country
City
Distance is calculated in your browser. Your city is not sent to us.
Type
Get notified of new trialsUnited States, all cities, all phases
Your ageShows only trials that take people your age.
Phase
  1. Albert Lea, United StatesAlso Eau Claire, Jacksonville, La Crosse, Mankato, Rochester, ScottsdaleAge 18+
  2. Trial-stage treatmentTaking people
    Tests a radiation seed device placed in recurrent brain tumors

    Tests a radiation seed device placed inside recurrent glioblastoma in adults.

    Columbus, United StatesAlso New York, ScottsdaleAge 18 to 85
  3. Trial-stage treatmentPhase 1/2Taking people
    Tests BAY 3713372 in adults with MTAP-deleted solid tumors

    Tests a new drug, BAY 3713372, in adults with certain solid tumors lacking MTAP.

    Aurora, United StatesAlso Birmingham, Boston, Denver, Duarte, Grand Rapids, Irving, Los Angeles, Milwaukee, …Age 18+
  4. Trial-stage treatmentPhase 2Taking people
    Silevertinib added to temozolomide for newly diagnosed glioblastoma with unmethylated MGMT and EGFRvIII

    Tests silevertinib plus temozolomide against temozolomide alone in adults with newly diagnosed glioblastoma.

    Ann Arbor, United StatesAlso Atlanta, Baltimore, Birmingham, Boston, Charlotte, Cleveland, Columbus, Detroit, …Age 18+
  5. Trial-stage treatmentPhase 1Soon in United States
    CM93 for glioblastoma that returned and has an EGFR change

    Tests the drug CM93 in adults with recurrent glioblastoma with EGFR changes.

    Boston, United StatesAlso New York, RochesterAge 18+
  6. Trial-stage treatmentPhase 1Soon in United States
    Testing YN003 injection for glioma that has returned or worsened

    Tests YN003 injection in adults with glioma that came back or progressed.

    Houston, United StatesAlso Los Angeles, San FranciscoAge 18 to 70
  7. Trial-stage treatmentPhase 1/2Taking people
    Testing selinexor added to temozolomide for brain tumors that returned

    Tests selinexor with temozolomide in adults with glioblastoma that has come back.

    Atlanta, United StatesAlso Aurora, Buffalo, Charlottesville, Chicago, Cincinnati, Cleveland, Columbus, Coral Gables, …Age 18+
  8. Trial-stage treatmentPhase 3Taking people
    Tests GammaTile with radiation and temozolomide after surgery for brain tumor

    Tests GammaTile with radiation and temozolomide in adults with newly diagnosed glioblastoma.

    Atlanta, United StatesAlso Baltimore, Charleston, Chicago, Columbia, Columbus, Fairfax, Greenville, Houston, …Age 18+
  9. Trial-stage treatmentPhase 1/2Soon in United States
    Tests ADI-PEG 20 with radiotherapy and temozolomide in young people with brain tumors

    Tests ADI-PEG 20 with radiotherapy and temozolomide in young people with new high-grade glioma.

    San Francisco, United StatesAge 3 to 39
  10. Trial-stage treatmentPhase 1/2Taking people
    Tests PLX038 in brain and spinal cord tumors, some with MYC or MYCN changes

    Tests PLX038 in adults with brain or spinal cord tumors, some with gene changes.

    Bethesda, United StatesAge 18 to 120
  11. Trial-stage treatmentPhase 1Taking people
    Tests M3554, a new antibody drug, in advanced solid tumors

    Tests M3554 in adults with soft tissue sarcoma or glioblastoma.

    Boston, United StatesAlso Houston, New YorkAge 18+
  12. Trial-stage treatmentPhase 1Taking people
    Tests Modified Stem Cell Virus Treatment for Recurrent Brain Tumors

    Tests stem cells carrying a cancer-killing virus in adults with glioblastoma that has returned.

    Chicago, United StatesAlso Duarte, Stanford, Winston-SalemAge 18+
  13. Trial-stage treatmentPhase 1Taking people
    Testing the oral drug GLIX1 in adults whose high-grade glioma has returned or worsened

    Tests GLIX1 capsules in adults with high-grade glioma that came back or progressed.

    Chicago, United StatesAlso New York, Palo Alto, TampaAge 18+
  14. Trial-stage treatmentPhase 2/3Taking people
    Tests several treatments in adults with newly diagnosed or returning glioblastoma

    Tests several drugs and radiation in adults with glioblastoma, a brain cancer.

    Atlanta, United StatesAlso Aurora, Austin, Birmingham, Boston, Charleston, Charlottesville, Cleveland, Columbus, …Age 18+
  15. Trial-stage treatmentPhase 1Taking people
    Testing ibrutinib with indoximod and chemotherapy in children with brain cancer

    Tests ibrutinib plus indoximod with oral chemotherapy in young people with brain cancer.

    Augusta, United StatesAge 3 to 25
  16. Trial-stage treatmentPhase 1Taking people
    RNA Vaccine Given Intravenously for Newly Diagnosed High-Grade Gliomas

    Tests an RNA vaccine made from tumor material in children and adults with brain tumors.

    Gainesville, United StatesAlso Washington D.C.Age 4+
  17. Trial-stage treatmentPhase 1Taking people
    Tests the TheraSphere GBM device in adults with recurrent glioblastoma

    Checks the safety of the TheraSphere GBM device in adults with returning glioblastoma.

    Baltimore, United StatesAlso Birmingham, Chicago, Houston, Jacksonville, New York, San Diego, San Francisco, St LouisAge 18+
  18. Trial-stage treatmentPhase 1Soon in United States
    Tests modified CD70 CAR T cell therapy in children with brain tumors

    Tests modified CD70 CAR T cells in children and young adults with high-grade glioma.

    Gainesville, United StatesAge 4 to 30
  19. Trial-stage treatmentPhase 2Taking people
    GI-102 with or without pembrolizumab before surgery for returning brain tumors

    Tests GI-102, alone or with pembrolizumab, in adults with returning brain tumors.

    Rochester, United StatesAge 18+
  20. Trial-stage treatmentPhase 1/2Taking people
    Tests zedoresertib with temozolomide in adults with glioblastoma brain tumors

    Tests zedoresertib with temozolomide in adults with recurrent or newly diagnosed glioblastoma.

    Chicago, United StatesAlso Dallas, Houston, New York, Salt Lake City, San Antonio, SeattleAge 18+

Where treatment stands

Tovorafenib, vorasidenib and trametinib, on the EU glioblastoma list, were first approved in the EU in 2024 or later.

Approved: 17

Officially approved for this disease in the EU, the US, Switzerland or France.

Human testing stage: 20

Being tested in people. Many treatments at this stage are never approved.

Animal testing stage: 3

Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.

Lab research stage: 1

Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.

Words used here

Placebo: a dummy treatment without the medicine, used for comparison.

Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.

Where this comes from

The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.

A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.

The EU medicines agency (EMA), ClinicalTrials.gov and the EU trials register, checked on 10 November 2026. Every treatment links to its own records; the texts are written by AI from them.

Medicines approved only in single countries are not included. We did not check in which countries a medicine is sold or paid for. Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 92 other open phase 2 trials are not listed.

Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for glioblastoma and other gliomas. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.

Not medical advice. Talk to your doctor before you change any treatment.

The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.

Support organisations

Patient organisations and helplines in United States, for you and your family.

Glioblastoma organisations in United States

  • National Cancer Institute – Cancer Information Service (CIS)

    NCI's contact center: information specialists answer cancer questions from patients, families and the public by phone, chat and email.

  • American Brain Tumor Association (ABTA)

    CareLine, a mentor programme for patients and caregivers, an online community and support groups.

  • American Cancer Society

    Nationwide US nonprofit helping people who face cancer: research, patient services, early detection, treatment information and education, with a cancer helpline on its site.

  • Brain Tumor Network (BTN)

    Free one-to-one navigation: help after a new diagnosis or a recurrence, trial and biomarker searches, second opinions and records.

  • Cactus Cancer Society

    Young adult cancer resource and community: support programs for people diagnosed with cancer as young adults.

  • Cancer Hope Network

    Nonprofit providing free one-on-one support to cancer patients and families by matching them with trained volunteers who have had a similar experience.

  • Cancer Nation

    Survivor-led US cancer advocacy organization (formerly the National Coalition for Cancer Survivorship) working on quality cancer care and survivorship resources.

  • Genetic and Rare Diseases Information Center

    NIH information center (GARD) providing reliable information on genetic and rare diseases to patients and families via website and contact center.

  • Glioblastoma Foundation

    Foundation whose mission is to transform glioblastoma treatment and research.

  • Imerman Angels

    Nonprofit offering free one-on-one cancer support and personalized mentoring that connects cancer fighters, survivors and caregivers with someone who has been there.

  • Musella Foundation for Brain Tumor Research & Information

    Foundation giving brain tumor patients and families emotional and financial support, treatment information and research funding.

  • National Brain Tumor Society (NBTS)

    A support and navigation team, online support conversations and a toolkit with a trial finder.

  • OurBrainBank

    Patient-led nonprofit for people with glioblastoma and care partners, offering guidance, advocacy, patient stories and patient-powered data collection.

  • Triage Cancer

    National nonprofit providing free education on legal and practical issues (insurance, employment, finances) for people with cancer and caregivers.

General support in United States

  • 988 Suicide & Crisis Lifeline

    US national 24/7 free and confidential lifeline for anyone in suicidal crisis or emotional distress, reachable by calling or texting 988 or by chat.

  • MedlinePlus

    Free, easy-to-read health information service of the US National Library of Medicine (NIH) on diseases, conditions, drugs and wellness.

International organisations

  • Global Coalition for Adaptive Research

    Non-profit that runs GBM AGILE, a large glioblastoma trial testing several new medicines.

  • The Brain Tumour Charity

    Funds brain tumour research and runs a support line, groups and counselling, from the UK.

Patient organisation umbrella bodies

Offer tissue or data

There are three ways to help research move faster.

Give tissue or bloodA biobank stores your sample so many research teams can use it.No open programme yet
Share your health dataA patient registry collects your health data, without your name, for research.How to join
Take part as a healthy volunteerStudies also need people without the disease, for comparison. Family and friends can help.Volunteer

Approved treatments

17 medicines are approved for glioblastoma in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.

Checked on 11 Nov 2026 in the official lists of the US (FDA), the EU (EMA), Japan (PMDA, approvals since April 2004), Switzerland (Swissmedic), France (ANSM, medicines approved in France only) and Taiwan (TFDA). For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. 3 uncertain matches are left out. Other countries' own approvals were not checked.

“Miracle cure” fact checker

Social media spreads misinformation. Paste what you read here, and we'll tell you whether there is scientific evidence behind it.

What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.

Before you pay for anything, ask three things

  1. Is there a published study in people?
  2. Can I have the full price in writing?
  3. What does my doctor say?

“Cures” others already fact-checked

See all 5

About glioblastoma

Sources: NCI PDQ, NCI, NHS, EANO, MedlinePlus

A fast-growing cancer that starts in the brain and can cause headaches, seizures, and changes in thinking or mood. It is the most common brain cancer in adults, and men get it more often than women. Treatment is usually surgery to remove as much of it as possible, then radiotherapy with a daily chemotherapy medicine called temozolomide. Researchers are testing new treatments in people, including medicines that help the immune system fight the cancer.

What is it?

Glioblastoma is a brain cancer that starts in astrocytes, star-shaped cells that help keep nerve cells healthy. Doctors call it a grade 4 tumour: it grows and spreads very quickly, and its cells look very different from normal cells.

It is the most common brain cancer in adults, making up about 35 to 40 in every 100 cancers that start in the brain, and it is more common in men. The cause is not known, and few risk factors are known; radiation to the head in the past raises the risk. Some genetic conditions that run in families, such as neurofibromatosis and Li-Fraumeni syndrome, may raise the risk of brain tumours.

The first signs

The signs depend on where the tumour is and how big it is.

  • new or worsening headaches, often in the morning;
  • feeling or being sick;
  • seizures (fits);
  • problems with vision, hearing or speech;
  • changes in mood, personality or concentration;
  • weakness, balance problems or trouble walking.

How doctors find out

A doctor checks how your brain, nerves, muscles and senses are working, and you may have brain scans, such as MRI or CT, to look for a tumour. Usually a small sample of the tumour (a biopsy) is taken, with a needle or during an operation, and a specialist looks at the cells to find out the type and grade. Tests on the tumour's genes help to plan treatment. A team of specialists guides you through the tests and treatment, and a specialist nurse is your main contact.

Current treatment

For adults under 70 in good general health: surgery to remove as much of the tumour as is safe, then radiotherapy with temozolomide chemotherapy, followed by six cycles of temozolomide.

Will it get worse?

Glioblastoma grows fast and usually cannot be removed completely by surgery. How it goes depends on the type and grade of the tumour, where it is, whether surgery can remove it, whether cancer cells are left after surgery, changes in its chromosomes, whether it is new or has come back, and your general health. NCI experts wrote in 2017 that about 15 in every 100 people were alive 5 years after diagnosis, up from almost none in the mid-1990s.

Medicines: what helps, and what to watch for

After surgery, most people have radiotherapy together with temozolomide, a chemotherapy medicine taken every day, and then temozolomide on its own. Chemotherapy can also be placed into the brain during the operation. If the cancer comes back, a targeted medicine called bevacizumab may be used. Other medicines control seizures, reduce swelling in the brain and ease pain.

Good to know:

  • your care team will explain the side effects of your own treatment plan;
  • You will have regular check-ups during and after treatment, and you may also have tests and scans.

Surgery and radiotherapy

For most people, surgery comes first: the surgeon removes as much of the tumour as possible. The operation can also take a sample for testing, or drain fluid that has built up. Radiotherapy uses high-energy rays aimed carefully at the tumour; you may have it after surgery to help stop the cancer coming back. A typical course is 30 treatments over 6 weeks.

Is there a cure?

No cure has been found yet. A grade 4 tumour usually cannot be removed completely. If a cure is not possible, treatment aims to limit the cancer and its symptoms and help you live longer. Researchers are testing new treatments in people, such as immunotherapy (medicines that use the immune system to fight cancer) and targeted drugs for brain tumours with certain gene changes. You can join a clinical trial before, during or after your first treatment.

See the 461 trials you can join

Median survival

About 15 to 18 months